ViroKey Flu A/B & RSV RT-PCR Extension Kit (for use with ViroKey SARS-CoV-2 RT-PCR Test v2.0) (RUO)

Integrated workflow for Influenza A, Influenza B, RSV and SARS-CoV-2 detection

PURPOSE

The ViroKey® Flu A/B & RSV RT-PCR Extension Kit (For use only with ViroKey SARS-CoV-2 RT-PCR Test v2.0), is used in conjunction with the ViroKey SARS-CoV-2 RT-PCR Test v2.0, is a fourplex, real-time PCR test. This test is intended for the qualitative detection of RNA from SARS-CoV-2, Influenza A, Influenza B, and Respiratory Syncytial Virus (RSV) in nasopharyngeal and oropharyngeal swabs from individuals. 

The ViroKey Flu A/B & RSV RT-PCR Extension Kit is configured only for use together with the ViroKey SARS-CoV-2 RT-PCR Test v2.0 on the Sentosa SX 101 instrument, with the ViroKey SX Virus Total Nucleic Acid Kit, in conjunction with Sentosa SA201 Real-Time PCR system.

Results are for the identification of SARS-CoV-2, Influenza A and B, or Respiratory Syncytial Virus (RSV) RNA. Positive results are indicative of the presence of SARS-CoV-2, Influenza A and B, or Respiratory Syncytial Virus (RSV) RNA. Negative results do not preclude the absence of SARS-CoV-2, Influenza A and B or RSV RNA. Mutations that arise within the highly conserved regions of the viral genome covered by both kits’ primers and / or probes may result in failure to detect the presence of the virus.

RUO: For research use only. Not for use in diagnostic procedures.

 

FEATURES AND BENEFITS

Supporting Clinical Research

  • Sensitive and robust
  • Differentially detect SARS-CoV-2, Influenza A, Influenza B & RSV
    (when used with ViroKey SARS-CoV-2 RT-PCR Test v2.0)

Maximising Laboratory Efficiency

  • Only 30 mins to 1 hour of hands-on time
  • Automation from sample to result with automated PCR result analysis
  • Test up to 46 samples (plus 2 controls) per automated run

Increasing Cost Effectiveness

  • Differentiate 4 pathogens in 1 run to save reagents and consumables cost
  • Comprehensive and fast result call-out to reduce patient management cost

WORKFLOW

SPECIFICATIONS

AttributeValue
Sample Types

Nasopharyngeal and oropharyngeal swabs

Targets

Influenza A: Matrix Protein
Influenza B: Matrix Protein
Human respiratory syncytial virus (RSV): M Protein

Limit of Detection (LoD)

Influenza A: 2.5 TCID50/mL
Influenza B: 10 TCID50/mL
Human respiratory syncytial virus (RSV): 4.5 TCID50/mL

Analytical Specificity No cross-reactivity observed

 

PRODUCT FLYERS

ORDERING INFORMATION

ProductPack SizeItem Number
ViroKey Flu A/B & RSV RT-PCR Extension Kit (4x48) RUO 8x48 301075
ViroKey SARS-CoV-2 RT-PCR Test v2.0 (8x48) EUA 8x48 301068
ViroKey SX Virus Total Nucleic Acid Kit (4x48) US-IVD 4x48 300677

For availability in your country, please contact your Vela Diagnostics sales representative.